{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:59:32Z","timestamp":1777139972417,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-0500-6-433","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T12:21:54Z","timestamp":1383049314000},"source":"Crossref","is-referenced-by-count":5,"title":["Development of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy"],"prefix":"10.1186","volume":"6","author":[{"given":"Welbert de Oliveira","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nydia Strachman","family":"Bacal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo Patussi","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Hissae","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira Deolinda","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Borri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Vidal","family":"Campregher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"issue":"10","key":"3553_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, et al: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012, 366 (10): 883-892. 10.1056\/NEJMoa1113205.","journal-title":"N Engl J Med"},{"issue":"11","key":"3553_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrurol.2012.185","volume":"9","author":"LK Boyd","year":"2012","unstructured":"Boyd LK, Mao X, Lu YJ: The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol. 2012, 9 (11): 652-664. 10.1038\/nrurol.2012.185.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3553_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/sj.bjc.6605971","volume":"104","author":"SL Cooke","year":"2011","unstructured":"Cooke SL, et al: Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer. 2011, 104 (2): 361-368. 10.1038\/sj.bjc.6605971.","journal-title":"Br J Cancer"},{"issue":"5","key":"3553_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K: Intra-tumour heterogeneity: a looking glass for cancer?. Nat Rev Cancer. 2012, 12 (5): 323-334.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3553_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3324\/haematol.2009.021212","volume":"95","author":"R Ratei","year":"2010","unstructured":"Ratei R, et al: Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans\u2019 cell sarcoma: evidence for hematopoietic plasticity. Haematologica. 2010, 95 (9): 1461-1466. 10.3324\/haematol.2009.021212.","journal-title":"Haematologica"},{"issue":"5","key":"3553_CR6","first-page":"232","volume":"107","author":"T Kontozoglou","year":"1983","unstructured":"Kontozoglou T, Skinnider LF: Concurrent appearance of multiple myeloma with other B-cell lymphoid neoplasms. A report of two cases. Arch Pathol Lab Med. 1983, 107 (5): 232-234.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"3553_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood.V66.2.291.291","volume":"66","author":"JP Fermand","year":"1985","unstructured":"Fermand JP, et al: Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood. 1985, 66 (2): 291-293.","journal-title":"Blood"},{"issue":"9","key":"3553_CR8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/1097-0142(19841101)54:9<1904::AID-CNCR2820540921>3.0.CO;2-E","volume":"54","author":"A Pines","year":"1984","unstructured":"Pines A, et al: Transformation of chronic lymphocytic leukemia to plasmacytoma. Cancer. 1984, 54 (9): 1904-1907. 10.1002\/1097-0142(19841101)54:9<1904::AID-CNCR2820540921>3.0.CO;2-E.","journal-title":"Cancer"},{"issue":"1","key":"3553_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2141.1985.tb02963.x","volume":"59","author":"JC Brouet","year":"1985","unstructured":"Brouet JC, et al: The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol. 1985, 59 (1): 55-66. 10.1111\/j.1365-2141.1985.tb02963.x.","journal-title":"Br J Haematol"},{"issue":"9","key":"3553_CR10","first-page":"982","volume":"85","author":"F Patriarca","year":"2000","unstructured":"Patriarca F, et al: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica. 2000, 85 (9): 982-985.","journal-title":"Haematologica"},{"issue":"1","key":"3553_CR11","first-page":"153","volume":"149","author":"D Tabernero","year":"1996","unstructured":"Tabernero D, et al: Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes. Am J Pathol. 1996, 149 (1): 153-161.","journal-title":"Am J Pathol"},{"issue":"3","key":"3553_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef M, Calame K: Regulation of plasma-cell development. Nat Rev Immunol. 2005, 5 (3): 230-242. 10.1038\/nri1572.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3553_CR13","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood.V74.6.2062.2062","volume":"74","author":"DL Saltman","year":"1989","unstructured":"Saltman DL, et al: Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood. 1989, 74 (6): 2062-2065.","journal-title":"Blood"},{"issue":"4","key":"3553_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0609.1995.tb00680.x","volume":"54","author":"PM Novak","year":"1995","unstructured":"Novak PM, et al: Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis. Eur J Haematol. 1995, 54 (4): 254-261.","journal-title":"Eur J Haematol"},{"issue":"3","key":"3553_CR15","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, et al: WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica. 2010, 102 (3): 83-87.","journal-title":"Pathologica"},{"issue":"3","key":"3553_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1179\/102453308X316121","volume":"13","author":"M AbdelSalam","year":"2008","unstructured":"AbdelSalam M, et al: The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia. Hematology. 2008, 13 (3): 147-153. 10.1179\/102453308X316121.","journal-title":"Hematology"},{"issue":"5","key":"3553_CR17","first-page":"529","volume":"88","author":"MO Elnenaei","year":"2003","unstructured":"Elnenaei MO, et al: Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. Haematologica. 2003, 88 (5): 529-537.","journal-title":"Haematologica"},{"issue":"5","key":"3553_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","volume":"181","author":"E Sebastian","year":"2012","unstructured":"Sebastian E, et al: Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype. Am J Pathol. 2012, 181 (5): 1879-1888. 10.1016\/j.ajpath.2012.07.028.","journal-title":"Am J Pathol"},{"issue":"2","key":"3553_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cancergencyto.2005.02.015","volume":"161","author":"FW Cremer","year":"2005","unstructured":"Cremer FW, et al: High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH. Cancer Genet Cytogenet. 2005, 161 (2): 116-124. 10.1016\/j.cancergencyto.2005.02.015.","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"3553_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s002770100328","volume":"80","author":"H Kaufmann","year":"2001","unstructured":"Kaufmann H, et al: Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma\u2013a report on two cases. Ann Hematol. 2001, 80 (8): 474-478. 10.1007\/s002770100328.","journal-title":"Ann Hematol"},{"issue":"12","key":"3553_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nrc1749","volume":"5","author":"JM Allan","year":"2005","unstructured":"Allan JM, Travis LB: Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer. 2005, 5 (12): 943-955. 10.1038\/nrc1749.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-6-433\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T23:29:06Z","timestamp":1596756546000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-433","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]},"article-number":"433"}}